These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Case-control study of risk factors for cervical squamous-cell neoplasia in Denmark. III. Role of oral contraceptive use. Kjaer SK, Engholm G, Dahl C, Bock JE, Lynge E, Jensen OM. Cancer Causes Control; 1993 Nov; 4(6):513-9. PubMed ID: 8280828 [Abstract] [Full Text] [Related]
16. Oral contraceptive use and cancer: final report from the Oxford-Family Planning Association contraceptive study. Vessey M, Yeates D. Contraception; 2013 Dec; 88(6):678-83. PubMed ID: 24090961 [Abstract] [Full Text] [Related]
18. HPV co-factors related to the development of cervical cancer: results from a population-based study in Costa Rica. Hildesheim A, Herrero R, Castle PE, Wacholder S, Bratti MC, Sherman ME, Lorincz AT, Burk RD, Morales J, Rodriguez AC, Helgesen K, Alfaro M, Hutchinson M, Balmaceda I, Greenberg M, Schiffman M. Br J Cancer; 2001 May 04; 84(9):1219-26. PubMed ID: 11336474 [Abstract] [Full Text] [Related]
19. Depot-medroxyprogesterone acetate, other injectable contraceptives, and cervical neoplasia. La Vecchia C. Contraception; 1994 Mar 04; 49(3):223-30. PubMed ID: 8200216 [Abstract] [Full Text] [Related]